Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma

Figure 2

The functional enrichment and prognostic analysis. (a, b) The enriched items in gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis. (c–f) Overall survival curve in LUSC patients with high/low expression of IL6, IL1B, ELANE, and CASP4. LUSC: lung squamous cell carcinoma; BP: biological process; CC: cellular component; MF: molecular function.

(a)

(b)

(c)

(d)

(e)

(f)